would be expected for non-BMT patients. The patients reported here fall into two groups, an early onset group associated with cold autoantibodies and a late onset group We reviewed the medical records of 293 patients who underwent allogeneic bone marrow transplants at the associated with warm antibodies. In the early group the antibodies occurred between 2 to 8 months and in the late Hammersmith Hospital between 1989 and 1994. There was clinical evidence of an autoimmune reaction against onset group between 6 and 18 months post-transplant. We discuss the relationship between these phenomena and the red cells in nine patients. Seven of these patients had significant haemolysis; the other two had red cell autorole of factors such as GVHD, relapse, CMV and immunosuppression and also the association with the regenerating agglutination. Haemolysis was resistant to treatment in three cases. Six of the nine patients had monoclonal Ig immune system following BMT. bands identified within 1 year of transplant. The autoimmune reaction could be classified broadly into two types: an early onset type (n = 4) beginning 2 to 8
autoimmune; antibody

Conditioning
The details of conditioning and anti-GVHD prophylaxis are Autoimmune haemolysis can present as a primary condition given in Table 1 . or as a phenomenon secondary to conditions such as lymphoproliferative or autoimmune diseases. A few cases of autoimmune haemolytic anaemia (AIHA) in patients folSerology lowing allogeneic bone marrow transplant have been described in the literature, usually associated with other Standard serological methods were employed. 8 The direct cytopenias. [1] [2] [3] [4] [5] [6] [7] At the Hammersmith Hospital, nine docuanti-globulin test (DAGT) was performed using polyspecmented cases of clinically significant autoimmune reaction ific antihuman globulin. When the DAGT was found to be against red blood cells occurring after allogeneic BMT have positive, further testing with specific anti-IgG, IgM, IgA been identified between 1989 and 1994. These cases came and anti-C3d reagents was carried out. Eluates were preto light because of abnormalities of blood count, blood film, pared with the ether technique. Eluates were tested by the biochemistry or cross-matching. During this period 293 indirect antiglobulin test (IAGT) using monospecific patients had been allografted, giving an incidence of 3.1% reagents as for the DAGT. Serum was tested for the presfor allogeneic BMT patients, which is much higher than ence of agglutinating antibodies, lytic antibodies and by the IAGT. Samples positive in screening tests were tested for specificity in titration using panels of red cells with known This group comprised the four patients (cases 6-9) in whom autoimmune reaction against red blood cells giving an incithe RCAI tended to develop early, at 2, 2, 4, and 8 months dence of 3.1%. Eight of these had a positive DAGT and post-transplant, respectively. The serology obtained in these the last (case No. 8) had cold agglutination evident on the cases was typical of cold-AIHA and showed some anti-Pr peripheral blood film with circulating cold reactive anti-red and anti-I specificity similar to that of cold-AIHA in noncell antibody but negative DAGT and eluate. The results transplant settings. Mycoplasma and EBV serology were of the serological investigations are shown in Table 2 . The negative in all four members of this group. Cases 7 and 8 patients fall into two distinct groups on the basis of serohad no evidence of clinically significant haemolysis despite logical findings at the time at which haemolysis developed:
titres against untreated cells of 1/64 and 1/256 respectively at 20°C. Case 6 required 25 units of red blood cells in a Warm type RCAI 10-week period. This group comprised five patients (cases 1-5). The RCAI generally arose later than group 2, ranging from 6 to 18
In the warm reactive group, despite any apparent specificity, all cases demonstrated a clear non-specific or panmonths post-BMT, with haemolysis in all cases. Haemolysis was most severe in case No. 2 who required 91 units reactive component. Testing against Rh-null cells was not performed. No ABO antibodies were detected and all of red blood cells in a period of 7 months. The serological findings were typical of warm-type AIHA and the relative patients were matched for Rh D type, excluding this antigen as a basis for the IHA. In the cold reactive group the antispecificities where present were also typical of AIHA aris- Table 2 The results of serological investigation of the nine patients Cases 1-5 were warm type and detected at 37°C. Cases 6-9 were cold type and detected by saline methods at 20°C. Patients 2 and 5 also had an allo anti-E (ie donor is E neg). All Rh specificities were enhanced by papainised cells. Patient 6 was lytic at 20°C in saline; patient 7 lysed papainised cells at 20°C; patients 8 and 9 showed no lysis. ND = not done; NS = nonspecific.
I and anti-Pr were extremely unlikely to be alloreactive and patients in this group (Nos 1 and 2) also developed CMV reactivation at the time of haemolysis making a total of one showed no detectable specificity. Overall, the serological findings were typical of a true autoimmune reaction.
four patients with this association. Cytogenetic analysis revealed that three of the six cases This was not identified in any of the donors or recipients before bone marrow harvest who all underwent routine of CML (Nos 1, 2 and 9) had a cytogenetic relapse prior to the haemolysis. In patient 1 this was further associated serological screening. The proportion of major and minor ABO mismatch in this group of patients was not signifiwith the appearance of some recipient type red blood cells. In patient 6 there was transient reversion of the ABO cantly different from the allogeneic transplant group as a whole (0.444 vs 0.477; P = 0.85 by 2 ). group to recipient type but the haemolysis persisted after it returned once more to donor type. Relapse does not, therefore, appear to be an important association with RCAI.
Relation of RCAI to clinical course
All patients had immunoglobulin studies performed at several points following BMT. Six of the nine cases (Nos 1, The clinical course of these patients is shown in Table 3 . In the cold reactive group the detection of the autoantibody 2, 6, 7, 8 and 9) had a monoclonal band visible by routine immunoelectrophoresis at some stage within a year of the coincided with the onset of GVHD in three cases (Nos. 6, 8 and 9). Case 8 presented with severe skin and gut GVHD transplant. However, only in cases 1 and 7 was it detectable at the time of RCAI. Immunofixation of the paraprotein in concurrently with the detection of agglutination which resolved with control of the GVHD. In case 6 haemolysis cases 7 and 8 revealed an IgG and an IgM respectively, whereas in both cases serology suggested that an IgM was was preceded 1 month earlier by GVHD of the liver. In case 9 it coincided with an exacerbation of skin GVHD likely to be responsible for the haemolysis. Three patients (5, 6 and 9) went on to develop chronic GVHD. and transient cytogenetic relapse. In this case, haemolysis resolved with improvement of GVHD and return to cytogenetic remission after reduction of the cyclosporin dose.
Treatment and outcome Cases 7 and 9 also suffered reactivation of CMV infection at the time of RCAI. In the warm reactive group there was Warm type RCAI: All five cases had clinically significant haemolysis requiring treatment. Cases 1 and 3 responded no associated GVHD with onset of haemolysis. The coincidence in the cold group may therefore simply represent an to prednisolone and immunoglobulin and prednisolone and splenectomy respectively, and have subsequently done well overlap in the time course of these two complications. Two Table 3 Clinical course of the patients Note that in patient 5 recipient cells were detected 2 months after haemolysis developed but no relapse of CML. In cases 1, 2 and 3, recipient cells were detected 12, 2 and 9 months respectively before haemolysis. In patient 9 there was transient cytogenetic relapse at the time of haemolysis both of which resolved after the cyclosporine dose was reduced. CMV+ indicates detection of CMV by DEAFF testing. without further haemolysis. Case 4 has been reported preonset group with autoantibodies of the warm reactive type occurring between 6 and 18 months after BMT. viously. 2 His haemolysis progressed to pancytopaenia and subsequently resolved after a stormy course requiring
The characteristics and the separate presentation of the two groups parallel the reconstitution of the donor immune prednisolone, azathioprine, splenectomy and total lymphoid irradiation. Cases 2 and 5 failed to respond to treatment system. Following BMT, donor B cells begin IgM production which reaches normal levels within 2 to 6 months and died from pneumonitis and multiple thromboembolism, respectively.
followed by IgG at between 3 to 18 months. 14,15 This may provide a rational explanation for the separation of the two groups. Paraproteins were detected in six of the cases which Cold type RCAI: The clinical courses of these patients are suggests that post-transplant B cell lymphopoiesis may be diverse. In two patients (7 and 8) with cold type antibodies initially oligo-or monoclonal. 16 The development of AIHA there was no evidence of clinically significant haemolysis.
at a time when immunoglobulin levels are returning to norHowever, both patients clearly had free antibody in the mal may therefore reflect the relative overgrowth of autoserum despite the negative DAGT in case 8. They were reactive B cell clones by a purely stochastic process. Parapdetected because of marked red cell agglutination. In the roteins are well known to arise after BMT but the incidence other two cases of cold type autoantibody, haemolysis was in this group (six of nine cases) is higher than the 18 in 42 associated with fatal GVHD. The relationship of the anticases studied by Hammarstrom and Smith. 17 body to BMT in these cases may be questioned but in no Although it is not known whether the antibody procase was there any clinical or serological evidence of mycoduction is T cell-dependent in these cases, it is presumed plasma or EBV infection to account for it. In addition, the that, like B cells, T cell reconstitution may be initially first three (6, 7 and 8) had detectable paraprotein within 2 oligoclonal and that the network of T cell regulation of B months of detection of the antibody. In case 9, a paraprotein cell function may be patchy, and with regard to some antiwas detected 18 months later. Furthermore, three cases (6, gens, poorly represented. The absence of certain T cell 8 and 9) were associated with GVHD and the fourth (7) clones with subsequent dysregulation of B cells may allow with reactivation of CMV. Overall, the clinical picture is production of autoantibodies 3 which would thus explain the of a cold autoantibody in association with defective regennumber of 'autoimmune' disorders following BMT such as eration of the immune system. Cases 7 and 8 resolved sponother cytopenias, thyroid disease, acquired haemophilia taneously, 9 after prednisolone but 6 was resistant to and others. It may be argued that among these, only the prednisolone and immunoglobulin.
haematological cytopenias are truly autoimmune. Clinically significant RCAI following BMT has been reported only rarely in the past but from evidence presented Discussion here and in a recent report by Drobyski et al it may be more common than previously thought. 4, 18 Moreover, the detected incidence of 3.1% is likely to be an underestimate Immune haemolysis may arise at several points following BMT. The earliest type is the immediate reaction between as some cases produce mild or minimal haemolysis and might have escaped clinical attention. Drobyski et al found donor red blood cells and recipient antibodies in the presence of major ABO/Rh mismatch. 9 A similar reaction may the frequency of autoimmune haemolysis in a group of patients following T cell depleted allogeneic BMT to be occur with minor mismatch when donor isohaemoagglutinins are infused. Immune haemolysis may also arise in the 3%. Interestingly, the onset was generally later in these patients (7-25 months post-BMT) and only one patient had first 3 weeks following BMT due to antibodies from the engrafting donor lymphocytes reacting against residual a cold type antibody. As in the present report, the clinical outcome was determined largely by associated post-transrecipient red blood cells (minor ABO/Rh mismatch). In this type, the antibodies usually disappear after 6 weeks postplant problems resulting in death of four of their seven patients. Two of their patients responded to immunosuptransplant. 10 The cases of RCAI described in this report fall into a pressive therapy, which again is in keeping with the cases reported here. distinct third group arising longer than 8 weeks post-BMT with features of a true autoimmune disorder. Despite the Tamura et al 7 in 1994 reported a case of cold agglutinin disease arising 3 weeks following BMT which showed antiapparent specificity of some antibodies, there is in most cases a non-specific or pan-reactive component which is Pr specificity as did two cases in this report. It arose in conjunction with CsA therapy and grade I GVHD. The earltypical of AIHA. When present, the apparent specificities of the antibodies were against antigens shared by both ier onset than in the cases reported here may have been hastened by a preceding episode of pericarditis, presumed donor and recipient. These features suggest that it is extremely unlikely that an alloimmune reaction was taking to be viral in origin. Interestingly, the cold agglutinin was monoclonal which suggests a primary dysfunction of B place, although it was not possible to demonstrate that the antibodies were of donor origin because allotype data were cells rather than of T cell regulation. Several other reports describe cases with multiple cytopnot available. It is reportedly unusual to detect any recipient antibody more than 4 months post-BMT, 11,12 although enias following BMT. 4, 5, 19, 20 These might be taken to suggest the presence of a common haemopoietic antigen longer periods have been reported. 13 These cases reported here fall into two distinct groups: against which the antibody reacts. The cases reported here do not support this hypothesis; moreover in adult Evans an early onset group with autoantibodies of the cold reactive type occurring between 2 and 8 months, and a late syndrome it is rare for the same antibody to bind to both there is no association between GVHD and onset of warm AIHA. The association may therefore not be significant. 
